Steven Edelman, MD introduces novel developments in the treatment of diabetes as Anne Peters, MD, Director, USC Clinical Diabetes Program, highlights the ITCA 650 device. The ITCA 650 eliminates adherence, so the patient can get the treatment they need at their convenience. The subcutaneous exenatide release system allows for improvements not only in the treatment of diabetes, but also in helping patients to lead simpler, happier lives.